Yifan Zhai

Yifan Zhai

Directeur Technique/Scientifique/R&D chez ASCENTAGE PHARMA GROUP INTERNATIONAL

Fortune : 160 M $ au 30/06/2026

63 ans
Health Technology
Consumer Services
Health Services

Profil

Yifan Zhai is currently Chief Medical Officer at Ascentage Pharma Group International Co., Ltd. since 2013.
Former positions include Director of the Pharmacology Department at Exelixis, Inc. from 2001 to 2003; Principal at Human Genome Sciences, Inc.; Chief Scientific Officer at Celladon Corp.
from 2007 to 2010; Principal at Bayer Pharmaceuticals Corp.; President of HealthQuest, Inc. from 2003 to 2005; President of The Chinese Biopharmaceutical Association from 2009 to 2010; and Chief Scientific Officer at Oncomax Acquisition Corp.
from 2005 to 2007.
Education includes doctorates from Michigan State University in 1993 and Sun Yat-Sen University in 1984.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
21/05/2026 37 742 091 ( 10,1 % ) 160 M $ 30/06/2026

Postes actifs de Yifan Zhai

SociétésPosteDébut
ASCENTAGE PHARMA GROUP INTERNATIONAL Directeur Technique/Scientifique/R&D 01/07/2013

Anciens postes connus de Yifan Zhai

SociétésPosteFin
The Chinese Biopharmaceutical Association
President 01/01/2010
Directeur Technique/Scientifique/R&D 01/01/2010
Oncomax Acquisition Corp.
Directeur Technique/Scientifique/R&D 01/01/2007
President 01/01/2005
EXELIXIS, INC. Corporate Officer/Principal 01/01/2003
Voir l'expérience en détail de Yifan Zhai

Formation de Yifan Zhai

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

95

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Health Technology

Health Technology

Bayer Pharmaceuticals Corp.

Consumer Services

Health Services

Consumer Services

The Chinese Biopharmaceutical Association

Health Technology

Oncomax Acquisition Corp.

  1. Bourse
  2. Insiders
  3. Yifan Zhai
🔇